Analytical Data
-
基因名
FLJ36180
- Application
-
别名
EC 6.3.2.-; FLJ36180; MGC138638; MGC138639; Probable E3 ubiquitin-protein ligase TRIML1; RING finger protein 209; RNF209
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8N9V2
-
表达区间
1-192aa
-
氨基酸序列
MKEMLRKFSTEITLDPATANAYLVLSEDLKSVKYGGSRQQLPDNPERFDQSATVLGTQIFTSGRHYWEVEVGNKTEWEVGICKDSVSRKGNLPKPPGDLFSLIGLKIGDDYSLWVSSPLKGQHVREPVCKVGVFLDYESGHIAFYNGTDESLIYSFPQASFQEALRPIFSPCLPNEGTNTDPLTICSLNSHV
-
分子量
47.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FLJ36180, also known as the hypothetical protein encoded by the FLJ36180 gene, has garnered interest in the field of molecular biology and protein research due to its potential role in various biological processes. Identified through various genomic and proteomic studies, this protein remains poorly characterized, prompting scientists to investigate its structure, function, and involvement in cellular mechanisms. Preliminary studies indicate that FLJ36180 may be implicated in signaling pathways, cellular regulation, or disease processes, particularly in cancer and other pathologies where its expression levels may vary. Understanding FLJ36180 could provide insights into its functional significance and potential as a biomarker or therapeutic target. Ongoing research involves recombinant expression of FLJ36180 to investigate its biochemical properties, interactions with other proteins, and functional assays in different cellular contexts. By elucidating its role, researchers aim to bridge the gap in our knowledge regarding this enigmatic protein, paving the way for future studies that could unravel its contributions to health and disease at the molecular level.
